Platelet Rich Fibrin and Fibrin Matrix: More Than Just Scaffolds?

The discussion focuses on platelet-rich fibrin (PRF) and its matrix (PRFM) within the context of second and third generation platelet products, presenting their definitions and clinical relevance compared to PRP (platelet-rich plasma). PRF acts as a scaffold that houses platelets and leukocytes, facilitating healing through cell signaling and growth factor release, while PRFM is essentially activated PRP that forms a clot. The presentation examines historical use, preparation methods, and the biological behavior of these products, with evidence suggesting PRF may enhance wound healing due to its ability to retain growth factors longer. However, the literature on skin rejuvenation and alopecia is less robust, with few studies yielding inconsistent results. While PRF shows promise for wound care, its superiority over PRP for other applications remains unproven, with studies often failing to demonstrate meaningful differences. Concerns are raised around potential complications from injecting clotted material, emphasizing the necessity for careful patient counseling and evidence-based practice. Ultimately, though PRF and PRFM offer unique properties as potential therapeutic agents, the current high-quality data predominantly support their use in direct wound healing rather than broader applications.